Literature DB >> 6402447

H-2 effects on cell-cell interactions in the response to single non-H-2 alloantigens. VI. H-2Kb mutants differentially regulate the immune response to the H-4.2 alloantigen.

P J Wettstein, R W Melvold.   

Abstract

Mice expressing mutant H-2Kb alleles were tested for their ability to generate cytotoxic effector T-cells specific for the non-H-2 histocompatibility alloantigen H-4.2. Cytotoxic effectors specific for H-4.2 are preferentially restricted by the Kb allele. Mutant Kb alleles were observed to differentially regulate the magnitude of the H-4.2-specific cytotoxic effector response. Mice expressing the Kbm5, Kbm6, Kbm7, and Kbm9 alleles generated cytotoxic T-cells to the same level as mice expressing the wild-type Kb allele. Kbm8 and Kbm11 responders generated intermediate levels of effectors, whereas Kbm1, Kbm3, and Kbm10 responders did not generate detectable levels of cytotoxic effectors. Kbm4 responders produced high levels of H-4.2-specific cytotoxic effectors that were variably reactive with wild-type Kb antigens with no H-4.2. The ability to generate H-4.2-specific effectors generally correlated with (1) the ability of mutant Kb molecules to present H-4.2 to wild-type Kb-restricted effectors, and (2) the position of the respective amino acid interchanges on the Kb molecule. Mutations that altered the amino acid sequence in the vicinity of the disulfide bond in the C1 domain had the greatest deleterious effects on Kb-controlled responsiveness to H-4.2. The only exception was the Kbm11 intermediate responder, which differs from Kbm3 in both responsiveness and in a single amino acid interchange. Therefore, the amino acid sequence in the vicinity of the disulfide bond in the C1 domain plays a prominent role in determining the H-4.2-specific immune response potential. These observations are the first to clearly demonstrate association between particular MHC gene product, amino acid sequences and immune responsiveness.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6402447     DOI: 10.1007/BF00364751

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  33 in total

1.  Anti-H-Y responses of H-2b mutant mice.

Authors:  E Simpson; R D Gordon; P R Chandler; D Bailey
Journal:  Eur J Immunol       Date:  1978-10       Impact factor: 5.532

2.  Further structural studies of the heavy chain of HLA antigens and its similarity to immunoglobulins.

Authors:  C Terhorst; R Robb; C Jones; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

3.  Inherited histocompatibility changes in progeny of irradiated and unirradiated inbred mice.

Authors:  D W Bailey; H I Kohn
Journal:  Genet Res       Date:  1965-11       Impact factor: 1.588

4.  Peptide map analyses of murine Ia antigens of the I-E subregion using HPLC.

Authors:  M McMillan; J M Cecka; L Hood; D B Murphy; H O McDevitt
Journal:  Nature       Date:  1979-02-22       Impact factor: 49.962

5.  Primary structure of murine major histocompatibility alloantigens: amino acid sequence of the cyanogen bromide fragment Ia (positions 139-228) from the H-2Kb molecule.

Authors:  H Uehara; B M Ewenstein; J M Martinko; S G Nathenson; T J Kindt; J E Coligan
Journal:  Biochemistry       Date:  1980-12-23       Impact factor: 3.162

Review 6.  Biochemistry of the gene products from murine MHC mutants.

Authors:  R Nairn; K Yamaga; S G Nathenson
Journal:  Annu Rev Genet       Date:  1980       Impact factor: 16.830

Review 7.  Genetic control of the immune response to Thy-1 antigens.

Authors:  M Zaleski; J Klein
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

Review 8.  The immune response genes of the major histocompatibility complex.

Authors:  B Benacerraf; R N Germain
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

9.  Structure of the heavy chain of the H-2Kk histocompatibility antigen.

Authors:  J B Rothbard; T P Hopp; G M Edelman; B A Cunningham
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

10.  Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness.

Authors:  R M Zinkernagel; A Althage; S Cooper; G Kreeb; P A Klein; B Sefton; L Flaherty; J Stimpfling; D Shreffler; J Klein
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

View more
  6 in total

1.  Biochemical analysis of related, independently arising histocompatibility mutants: bm17 and KB-98 enlarge the "bg series" of H-2Kb mutants.

Authors:  G M Pfaffenbach; R W Melvold; S G Nathenson
Journal:  Biochem Genet       Date:  1990-08       Impact factor: 1.890

2.  Mutant HLA-A2 antigens as restricting elements for virus-specific cytotoxic T cells.

Authors:  J S Gaston; L E Wallace; A B Rickinson; M A Epstein; D Pious
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

3.  H4 and CTT-2 minor histocompatibility antigens: concordant genetic linkage and migration in two-dimensional peptide separation.

Authors:  W K Nevala; P J Wettstein
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  Unusual association of beta 2-microglobulin with certain class I heavy chains of the murine major histocompatibility complex.

Authors:  Y Bushkin; J S Tung; A Pinter; J Michaelson; E A Boyse
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

5.  Cytotoxic T lymphocyte nonresponsiveness to the male antigen H-Y in the H-2Db mutants bm13 and bm14. Complementation of the response in F1 crosses with the I-Ab mutant bm12 nonresponder and failure of B6 or Db mutant mice tolerant of each other to respond to allogeneic male cells.

Authors:  L P De Waal; R W Melvold; C J Melief
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

6.  Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants.

Authors:  J S Gaston; A B Rickinson; M A Epstein
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.